Skip to main content
. Author manuscript; available in PMC: 2007 Jan 3.
Published in final edited form as: Rev Physiol Biochem Pharmacol. 2004 Sep 29;152:93–109. doi: 10.1007/s10254-004-0032-6

Table 1.

Signaling of heterotrimeric G-proteins and their modulating toxins

Subfamily Signalinga Modulating toxin Toxin effect on Gα Referencesb
Gi subfamily Gi1 ↓AC PT Inhibition (a) (b)
Gi2 ↓AC PT Inhibition (a) (b)
Gi3 ↓AC PT Inhibition (a) (b)
Go ↓Ca2+ channels PT Inhibition (a) (b)
Gt ↑cGMP-PDE PT Inhibition (a) (b) (c)
CT Activation (a) (b) (d)
Ggust ↑PDE PT ? (e)
Gz ↓AC ? ? (f) (g)
Gs subfamily Gs ↑AC CT Activation (a) (b)
Golf ↑AC CT Activation (h)
Gq subfamily Gq ↑PLCβ, ↑Rho PMT Activation/Inhibitionc (i) (j) (k)
G11 ↑PLCβ, ↑Rho ? ? (k)
G14 ↑PLCβ ? ?
G15 ↑PLCβ ? ?
G16 ↑PLCβ ? ?
G12 subfamily G12 ↑Rho ? ?
G13 ↑Rho ? ?
a

AC: adenylate cyclase; PDE: phosphodiesterase; PLC: phopholipase C

c

Initial activation, followed by uncoupling of Gq signaling. Prolonged treatment with PMT results in inhibition